IP Library Assignment 073465/0241
Patent Assignment
Reel/Frame 073465/0241

Change of Name

Recorded: 2025-11-05 Pages: 4
Assignor
CREALTA PHARMACEUTICALS LLC
Executed: 2016-01-13
Assignee
HORIZON PHARMA RHEUMATOLOGY LLC
150 S. SAUNDERS RD., LAKE FOREST, ILLINOIS, 60045
Covered Property (1)
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Application: 19/345,445 →
Publication: US 2026/0023073
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 5, 2025
From: ROSARIO-JANSEN, THERESA; WRIGHT, DAVID ERICK
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 072794/0436 →
Assignment of Assignor's Interest Nov 5, 2025
From: SAVIENT PHARMACEUTICALS, INC.
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 073465/0174 →
Assignment of Assignor's Interest Nov 5, 2025
From: HORIZON PHARMA RHEUMATOLOGY LLC
To: HORIZON THERAPEUTICS USA, INC.
Reel/Frame 073465/0721 →